Sarah Pringle

THL investment values Bazaarvoice at $1.5b-plus, Ares gains secondaries business through $1b Landmark acquisition, Avista sees opportunity to simplify early-stage drug-development

THL's investment in Bazaarvoice puts company at an over $1.5 billion valuation and Ares agrees to buy secondaries shop Landmark Partners.

Avista backs eMolecules as pharma seeks to simplify supply chain

Accounting for eMolecules and its pending investment in French drugmaker Cooper, Avista Fund V is 50% deployed.

Astorg to acquire Corialis from CVC Capital Partners

Corialis’ management will reinvest a significant part of their proceeds alongside Astorg.

Kinderhook recapitalizes Cameron Wire & Cable

Kinderhook operating partners will join Cameron W&C’s management and board of directors, including Ed Flynn, former CEO of International Wire Group, and Craig York, CEO of Kinderhook portfolio company, Copperweld.

Sponsors bid $1bn-plus to advance in Bristol Hospice sale process

Webster Equity's sale process for the hospice-care provider formally kicked off in February via Goldman Sachs and Houlihan Lokey.

WindRose's myNexus goes to Anthem for $800m-plus, PEI Media launches new publication for sustainability, DOJ extends review of United's $8bn Change Healthcare acquisition

WindRose-backed myNexus is sold to Anthem and PE Hub's parent company launches new sustainability publication.

WindRose's myNexus goes to Anthem for $800m-plus

Having already made close to 15x its money on myNexus as of June 2019, WindRose looks poised to generate a handsome return.

Price is not the dominating factor in a SPAC-off, SEC inquiries aimed at SPAC market anticipated, Why Unit4 found itself a rare find in Europe

Sounding off on SPACs and why Unit4 emerged as a highly sought-after target when it hit the market a few months back.

When picking the right SPAC partner, it's not price you're after

The sell-side process aimed at SPACs is more limited than a typical M&A process, and in most cases, price isn't the dominating factor when determining the best partner, panelists said at a virtual McDermott Will & Emery conference.

Arcline Investment Management invests in PDC Machines

The company is the No. 1 supplier of proprietary hydrogen compressors used in hydrogen energy applications worldwide.